Attenuating adaptive VEGF-A and IL-8 signaling restores durable tumor control in AR-antagonist-treated prostate cancers
Pamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, Judith M Manley, Chee Wee Ong, Jenny Worthington, Ian G Mills, Daniel B Longley, James P Quigley, Amina Zoubedi, Johann S de Bono, Elena Deryugina, Melissa J LaBonte, David J J Waugh
Dive into the research topics of 'Attenuating adaptive VEGF-A and IL-8 signaling restores durable tumor control in AR-antagonist-treated prostate cancers'. Together they form a unique fingerprint.